Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Equillium Inc (NQ: EQ ) 1.129 -0.001 (-0.08%) Streaming Delayed Price Updated: 9:31 AM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Equillium Inc < Previous 1 2 3 4 5 6 Next > Equillium Announces Publication of Data in the Journal of Clinical Investigation Highlighting the Importance of the CD6-ALCAM Pathway in the Pathogenesis of Lupus Nephritis January 04, 2022 From Equillium, Inc. Via Business Wire Equillium To Reassess Potential For Its Asthma Trials January 04, 2022 Equillium Inc's (NASDAQ: EQ) Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective. The data demonstrated an on-target... Via Benzinga Equillium Announces Data from Phase 1b EQUIP Study in Patients with Uncontrolled Asthma January 04, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Additional Patient Data at ASH 2021 Demonstrating Continued Positive and Durable Clinical Responses in Acute Graft-Versus-Host Disease Patients Treated with Itolizumab December 13, 2021 From Equillium, Inc. Via Business Wire Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates November 10, 2021 From Equillium, Inc. Via Business Wire Equillium to Present at Two Upcoming Investor Conferences November 09, 2021 From Equillium, Inc. Via Business Wire Equillium Presents Clinical Data from EQUALISE Phase 1b Study in Lupus Patients at the American Society of Nephrology Annual Meeting November 05, 2021 From Equillium, Inc. Via Business Wire Equillium Presents Interim Safety Data from First Cohort of Asthma Patients in Phase 1b EQUIP Study at the American College of Allergy, Asthma & Immunology Meeting November 05, 2021 From Equillium, Inc. Via Business Wire Equillium Announces Two Abstracts Accepted for Presentation at the 63rd ASH Annual Meeting and Exposition November 04, 2021 From Equillium, Inc. Via Business Wire Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients November 02, 2021 Equillium Inc (NASDAQ: EQ) announced interim data from the Type A portion of the Phase 1b EQUALISE study in systemic lupus erythematosus (SLE) patients. Data were... Via Benzinga Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting November 02, 2021 From Equillium, Inc. Via Business Wire Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting October 18, 2021 From Equillium, Inc. Via Business Wire Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021 September 30, 2021 From Equillium, Inc. Via Business Wire The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference September 22, 2021 From Equillium, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 September 15, 2021 Upgrades For Alcoa Corp (NYSE: Via Benzinga Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 08, 2021 From Equillium, Inc. Via Business Wire 60 Biggest Movers From Yesterday August 24, 2021 Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... Via Benzinga Equillium's Itolizumab Reduces Urine Protein In Lupus Patients August 12, 2021 Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 11, 2021 Gainers Hims & Hers Health (NYSE:HIMS)... Via Benzinga Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis August 11, 2021 From Equillium, Inc. Via Business Wire Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update August 10, 2021 From Equillium, Inc. Via Business Wire Equillium to Present at the BTIG Virtual Biotechnology Conference August 05, 2021 From Equillium, Inc. Via Business Wire Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab July 13, 2021 Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data July 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 12 Health Care Stocks Moving In Monday's After-Market Session July 12, 2021 Gainers SCWorx (NASDAQ:WORX) shares rose... Via Benzinga 64 Biggest Movers From Friday June 14, 2021 Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Friday's Intraday Session June 11, 2021 Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... Via Benzinga Equillium's Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients June 11, 2021 Equillium Inc (NASDAQ: EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 09, 2021 Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.